We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+12.85%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$525B
AUM Growth
+$44.8B
Cap. Flow
-$15.7B
Cap. Flow %
-2.98%
Top 10 Hldgs %
23.82%
Holding
13,823
New
1,903
Increased
5,066
Reduced
5,122
Closed
1,577

Sector Composition

Rank Sector Weight
1 Technology 2.06%
2 Consumer Discretionary 1.41%
3 Healthcare 0.83%
4 Financials 0.79%
5 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCYX icon
11876
PUT
SCYNEXIS
SCYX
$53M
$24.3K ﹤0.01%
1,363
-887
-39% -$13K
XFOR icon
11877
CALL
X4 Pharmaceuticals
XFOR
$413M
$24K ﹤0.01%
953
+293
+44% +$7.13K
WORX
11878
DELISTED
SCWORX CORP NEW
WORX
$24K ﹤0.01%
870
+820
+1,640% +$25.4K
GALT icon
11879
CALL
Galectin Therapeutics
GALT
$396M
$23.9K ﹤0.01%
14,400
-700
-5% -$1.36K
QUBT icon
11880
Quantum Computing Inc
QUBT
$1.92B
$23.8K ﹤0.01%
26,013
-57,862
-69% -$49.7K
VIRX
11881
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$23.6K ﹤0.01%
+41,412
New +$25.4K
CRVS icon
11882
CALL
Corvus Pharmaceuticals
CRVS
$1.22B
$23.6K ﹤0.01%
13,400
-3,400
-20% -$4.97K
VFF icon
11883
PUT
Village Farms International
VFF
$346M
$23.6K ﹤0.01%
31,000
+19,200
+163% +$14.6K
HTOO icon
11884
Fusion Fuel Green
HTOO
$14.7M
$23.5K ﹤0.01%
600
-668
-53% -$20.7K
RDHL
11885
CALL
Redhill Biopharma
RDHL
$3.68M
$23.5K ﹤0.01%
644
CLPS icon
11886
CLPS Inc
CLPS
$31.6M
$23.5K ﹤0.01%
22,585
-11,183
-33% -$11.6K
NAGE
11887
Niagen Bioscience
NAGE
$257M
$23.4K ﹤0.01%
+16,384
New +$22.8K
TLPH icon
11888
CALL
Talphera
TLPH
$65.4M
$23.3K ﹤0.01%
+31,500
New +$20K
ACRS icon
11889
PUT
Aclaris Therapeutics
ACRS
$957M
$23.2K ﹤0.01%
22,100
-51,900
-70% -$158K
TRVI icon
11890
Trevi Therapeutics
TRVI
$2.52B
$23.1K ﹤0.01%
+17,207
New +$26.1K
BIRD icon
11891
CALL
Smartbird Inc
BIRD
$28M
$22.9K ﹤0.01%
+930
New +$18.4K
EFTR
11892
CALL
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$22.8K ﹤0.01%
+1,944
New +$26.1K
CLNN icon
11893
PUT
Clene
CLNN
$55.9M
$22.8K ﹤0.01%
3,795
-535
-12% -$4.66K
AGEN
11894
PUT
Agenus
AGEN
$370M
$22.7K ﹤0.01%
1,365
-380
-22% -$6.3K
FMTO
11895
DELISTED
Femto Technologies Inc. Common Stock
FMTO
0
MIST icon
11896
Milestone Pharmaceuticals
MIST
$146M
$22.2K ﹤0.01%
+13,299
New +$36.1K
ICCT
11897
DELISTED
iCoreConnect
ICCT
$21.7K ﹤0.01%
+876
New +$30.2K
NEWP
11898
CALL
New Pacific Metals
NEWP
$1.31B
$21.6K ﹤0.01%
+11,300
New +$19.5K
BKKT.WS icon
11899
Bakkt Inc Warrants
BKKT.WS
$216K
$21.6K ﹤0.01%
65,344
+31
+0% +$6
IGC icon
11900
IGC Pharma
IGC
$31.5M
$21.5K ﹤0.01%
76,872
+22,321
+41% +$6.92K

Similar funds

Jeff Yass's Q4 2023 Portfolio in Review

As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
  • Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
  • Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
  • Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
  • Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
  • Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
  • Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.